Hematopoietic progenitor cell transplantation in multiple myeloma

The median survival of conventionally treated patients with multiple myeloma is 3 years. Modifications of conventional chemotherapy and the administration of interferon-α have failed to show an improved survival in most randomized trials. Therapy with dose-escalated alkylating agents (i. e. melphala...

Full description

Saved in:
Bibliographic Details
Main Authors: Goldschmidt, Hartmut (Author) , Hegenbart, Ute (Author) , Haas, Rainer (Author) , Hunstein, Werner (Author)
Format: Article (Journal)
Language:English
Published: 1995
In: Onkologie
Year: 1995, Volume: 18, Issue: 6, Pages: 518-523
ISSN:1423-0240
DOI:10.1159/000218652
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1159/000218652
Get full text
Author Notes:H. Goldschmidt, U. Hegenbart, R. Haas, W. Hunstein

MARC

LEADER 00000caa a2200000 c 4500
001 1925774902
003 DE-627
005 20250717014115.0
007 cr uuu---uuuuu
008 250515s1995 xx |||||o 00| ||eng c
024 7 |a 10.1159/000218652  |2 doi 
035 |a (DE-627)1925774902 
035 |a (DE-599)KXP1925774902 
035 |a (OCoLC)1528045342 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
245 1 0 |a Hematopoietic progenitor cell transplantation in multiple myeloma  |c H. Goldschmidt, U. Hegenbart, R. Haas, W. Hunstein 
264 1 |c 1995 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Elektronische Reproduktion der Druck-Ausgabe 11. Mai 2009 
500 |a Gesehen am 15.05.2025 
520 |a The median survival of conventionally treated patients with multiple myeloma is 3 years. Modifications of conventional chemotherapy and the administration of interferon-α have failed to show an improved survival in most randomized trials. Therapy with dose-escalated alkylating agents (i. e. melphalan 140 mg/m2) induced higher remission rates than conventional treatment. If followed by allogeneic or autologous hematopoietic progenitor cell transplantation, the hematotoxicity of the described dose-escalated treatment could be reduced. Results of transplantation trials are summarized and discussed. The transplantation of autologous peripheral blood progenitor cells results in a faster hematopoietic reconstitution and a decreased high-dose therapy-related morbidity compared to autologous bone marrow and should therefore be preferred. Although the randomized French myeloma trial showed a significant survival advantage for patients following autologous transplantation, further randomized prospective studies are required to evaluate the role of blood progenitor cell transplantation after high-dose treatment in multiple myeloma. Prognostical factors and future treatment modalities for myeloma are discussed. 
700 1 |a Hegenbart, Ute  |e VerfasserIn  |0 (DE-588)1028373708  |0 (DE-627)73062157X  |0 (DE-576)35901903X  |4 aut 
700 1 |a Haas, Rainer  |d 1955-  |e VerfasserIn  |0 (DE-588)173773524  |0 (DE-627)698678141  |0 (DE-576)134613805  |4 aut 
700 1 |a Hunstein, Werner  |d 1928-2012  |e VerfasserIn  |0 (DE-588)1012782662  |0 (DE-627)699775833  |0 (DE-576)345935667  |4 aut 
773 0 8 |i Enthalten in  |t Onkologie  |d Basel : Karger, 1978  |g 18(1995), 6, Seite 518-523  |h Online-Ressource  |w (DE-627)300595417  |w (DE-600)1483097-8  |w (DE-576)105282863  |x 1423-0240  |7 nnas  |a Hematopoietic progenitor cell transplantation in multiple myeloma 
773 1 8 |g volume:18  |g year:1995  |g number:6  |g pages:518-523  |g extent:6  |a Hematopoietic progenitor cell transplantation in multiple myeloma 
856 4 0 |u https://doi.org/10.1159/000218652  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20250515 
993 |a Article 
994 |a 1995 
998 |g 1012782662  |a Hunstein, Werner  |m 1012782662:Hunstein, Werner  |d 910000  |d 910100  |e 910000PH1012782662  |e 910100PH1012782662  |k 0/910000/  |k 1/910000/910100/  |p 4  |y j 
998 |g 173773524  |a Haas, Rainer  |m 173773524:Haas, Rainer  |d 910000  |d 910100  |e 910000PH173773524  |e 910100PH173773524  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1028373708  |a Hegenbart, Ute  |m 1028373708:Hegenbart, Ute  |d 910000  |d 910100  |e 910000PH1028373708  |e 910100PH1028373708  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1925774902  |e 4724776374 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"name":{"displayForm":["H. Goldschmidt, U. Hegenbart, R. Haas, W. Hunstein"]},"title":[{"title_sort":"Hematopoietic progenitor cell transplantation in multiple myeloma","title":"Hematopoietic progenitor cell transplantation in multiple myeloma"}],"id":{"doi":["10.1159/000218652"],"eki":["1925774902"]},"person":[{"given":"Hartmut","roleDisplay":"VerfasserIn","role":"aut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"family":"Hegenbart","display":"Hegenbart, Ute","roleDisplay":"VerfasserIn","role":"aut","given":"Ute"},{"given":"Rainer","family":"Haas","display":"Haas, Rainer","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Werner","display":"Hunstein, Werner","family":"Hunstein","roleDisplay":"VerfasserIn","role":"aut"}],"relHost":[{"part":{"extent":"6","volume":"18","pages":"518-523","text":"18(1995), 6, Seite 518-523","year":"1995","issue":"6"},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.1978 - 36.2013"],"origin":[{"publisherPlace":"Basel","dateIssuedKey":"1978","publisher":"Karger","dateIssuedDisp":"1978-2013"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["1483097-8"],"eki":["300595417"],"issn":["1423-0240"]},"recId":"300595417","note":["Gesehen am 15.12.2023"],"language":["ger"],"title":[{"title":"Onkologie","subtitle":"international journal for cancer research and treatment","title_sort":"Onkologie"}],"disp":"Hematopoietic progenitor cell transplantation in multiple myelomaOnkologie"}],"recId":"1925774902","note":["Elektronische Reproduktion der Druck-Ausgabe 11. Mai 2009","Gesehen am 15.05.2025"],"origin":[{"dateIssuedDisp":"1995","dateIssuedKey":"1995"}],"physDesc":[{"extent":"6 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a GOLDSCHMIDHEMATOPOIE1995